Biological functions
Function Type | Function ID | Description | GeneRatio | BgRatio | pvalue | padjust | qvalue | GeneCount | RABCID | |
---|---|---|---|---|---|---|---|---|---|---|
KEGG | hsa05169 | Epstein-Barr virus infection | 68/1141 | 202/8135 | 0.000000000000653 | 0.000000000215 | 0.000000000151 | 68 | RABC51 | |
KEGG | hsa05144 | Malaria | 25/1141 | 50/8135 | 0.00000000137 | 0.000000204 | 0.000000144 | 25 | RABC51 | |
KEGG | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 38/1141 | 100/8135 | 0.00000000186 | 0.000000204 | 0.000000144 | 38 | RABC51 | |
KEGG | hsa04666 | Fc gamma R-mediated phagocytosis | 37/1141 | 97/8135 | 0.00000000269 | 0.000000221 | 0.000000156 | 37 | RABC51 | |
KEGG | hsa04662 | B cell receptor signaling pathway | 33/1141 | 82/8135 | 0.00000000398 | 0.000000262 | 0.000000185 | 33 | RABC51 | |
KEGG | hsa05416 | Viral myocarditis | 27/1141 | 60/8135 | 0.00000000578 | 0.000000317 | 0.000000223 | 27 | RABC51 | |
KEGG | hsa04064 | NF-kappa B signaling pathway | 37/1141 | 104/8135 | 0.0000000243 | 0.00000114 | 0.000000803 | 37 | RABC51 | |
KEGG | hsa04062 | Chemokine signaling pathway | 56/1141 | 192/8135 | 0.0000000286 | 0.00000118 | 0.000000827 | 56 | RABC51 | |
KEGG | hsa04659 | Th17 cell differentiation | 37/1141 | 108/8135 | 0.0000000758 | 0.00000256 | 0.0000018 | 37 | RABC51 | |
KEGG | hsa04514 | Cell adhesion molecules | 46/1141 | 149/8135 | 0.0000000777 | 0.00000256 | 0.0000018 | 46 | RABC51 | |
KEGG | hsa04060 | Cytokine-cytokine receptor interaction | 75/1141 | 295/8135 | 0.0000000897 | 0.00000268 | 0.00000189 | 75 | RABC51 | |
KEGG | hsa05164 | Influenza A | 50/1141 | 171/8135 | 0.000000146 | 0.00000399 | 0.00000281 | 50 | RABC51 | |
KEGG | hsa05162 | Measles | 43/1141 | 139/8135 | 0.000000194 | 0.0000049 | 0.00000345 | 43 | RABC51 | |
KEGG | hsa04640 | Hematopoietic cell lineage | 34/1141 | 99/8135 | 0.000000239 | 0.00000561 | 0.00000395 | 34 | RABC51 | |
KEGG | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 54/1141 | 194/8135 | 0.000000277 | 0.00000575 | 0.00000405 | 54 | RABC51 | |
KEGG | hsa04660 | T cell receptor signaling pathway | 35/1141 | 104/8135 | 0.00000028 | 0.00000575 | 0.00000405 | 35 | RABC51 | |
KEGG | hsa04380 | Osteoclast differentiation | 40/1141 | 128/8135 | 0.000000383 | 0.00000741 | 0.00000521 | 40 | RABC51 | |
KEGG | hsa04630 | JAK-STAT signaling pathway | 47/1141 | 162/8135 | 0.000000444 | 0.00000811 | 0.00000571 | 47 | RABC51 | |
KEGG | hsa05323 | Rheumatoid arthritis | 32/1141 | 93/8135 | 0.000000512 | 0.00000887 | 0.00000624 | 32 | RABC51 | |
KEGG | hsa04650 | Natural killer cell mediated cytotoxicity | 40/1141 | 131/8135 | 0.000000753 | 0.000012 | 0.00000845 | 40 | RABC51 | |
KEGG | hsa05330 | Allograft rejection | 18/1141 | 38/8135 | 0.000000802 | 0.000012 | 0.00000845 | 18 | RABC51 | |
KEGG | hsa05340 | Primary immunodeficiency | 18/1141 | 38/8135 | 0.000000802 | 0.000012 | 0.00000845 | 18 | RABC51 | |
KEGG | hsa05332 | Graft-versus-host disease | 19/1141 | 42/8135 | 0.000000964 | 0.0000138 | 0.00000971 | 19 | RABC51 | |
KEGG | hsa04658 | Th1 and Th2 cell differentiation | 31/1141 | 92/8135 | 0.00000129 | 0.0000177 | 0.0000125 | 31 | RABC51 | |
KEGG | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 30/1141 | 89/8135 | 0.0000019 | 0.000025 | 0.0000176 | 30 | RABC51 | |
KEGG | hsa05166 | Human T-cell leukemia virus 1 infection | 57/1141 | 222/8135 | 0.00000232 | 0.0000293 | 0.0000206 | 57 | RABC51 | |
KEGG | hsa05132 | Salmonella infection | 62/1141 | 249/8135 | 0.00000254 | 0.000031 | 0.0000218 | 62 | RABC51 | |
KEGG | hsa04612 | Antigen processing and presentation | 27/1141 | 78/8135 | 0.00000346 | 0.0000407 | 0.0000286 | 27 | RABC51 | |
KEGG | hsa04668 | TNF signaling pathway | 34/1141 | 112/8135 | 0.00000582 | 0.000066 | 0.0000465 | 34 | RABC51 | |
KEGG | hsa05221 | Acute myeloid leukemia | 24/1141 | 67/8135 | 0.0000061 | 0.0000669 | 0.0000471 | 24 | RABC51 |